MedTrace Logo

Hepatic Vein-sparing Hepatectomy for Colorectal Liver Metastases at the Caval Confluence

NCT02391207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-03-18

No results posted yet for this study

Summary

Major hepatectomies are generally selected for tumors involving the hepatic vein (HV) at the caval confluence (CC). As alternative, HV reconstruction has been proposed. The present study aimed to evaluate the feasibility and safety of a HV-sparing policy guided by intraoperative ultrasonography (IOUS) in a cohort of patients having at least one colorectal liver metastasis (CLM) in contact with a HV at CC. HV section can be avoided in the large majority of cases thanking to CLMs detachment or to HV partial resection or reconstruction: this policy seems feasible, safe, reduces the need of major hepatectomies, and oncologically provides an adequate local control.

Conditions

  • Secondary Malignant Neoplasm of Liver

Interventions

PROCEDURE

Hepatic vein-sparing hepatectomy

HV detachment, partial resection and section on the basis of HV-CLM relationship

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Principal Investigators

  • Guido Torzilli, MD,PhD,FACS · Department of Hepatobiliary and General Surgery, University of Milan, Humanitas Research Hospital, Rozzano, Milan, Italy

  • Fabio Procopio, MD · Department of Hepatobiliary and General Surgery, University of Milan, Humanitas Research Hospital, Rozzano, Milan, Italy

Eligibility

Min Age
28 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-12-31
Completion
2014-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391207 on ClinicalTrials.gov